): The core continues to function as a major source of invaluable resources for Projects 1, 2, 3 and 4. Major functions and achievements are listed below. Function 1 is largely performed at MDACC, while the other functions are performed at UTSW. 1) Sample collection. More than 250 lobectomy specimens have been collected, along with blood samples and clinical data. 2) Coordinate transfer and storage of samples from Project 4 Chemoprevention Trial for study at UTSW. These samples are obtained from MDACC, logged in and distributed to investigators at UTSW for molecular analyses. 3) and 4) Establish and characterize paired cell lines from SCLC and NSCLC tumors. More than 35 pairs of B-lymphoblastoid/lung cancer paired cell lines have been established, characterized and extensively allelotyped. 5) We have established a laser capture microdissection facility as a SPORE resource. 6) DNA and RNA has been prepared from tumors, non-malignant tissues and cell lines and over 500 aliquots have been distributed to SPORE investigators. 7) We have established collaborations with other investigators at other SPORE sites, exchanged materials with them, and instigated collaborative projects. 8) We have developed a simple, rapid method for the preparation of epithelial cells from malignant and non-malignant tissues which provide a source of high quality DNA and RNA. Future work will concentrate on preparing and distributing samples collected and processed by this """"""""EASI"""""""" method.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
3P50CA070907-05S8
Application #
6589743
Study Section
Project Start
2000-09-01
Project End
2003-04-30
Budget Start
Budget End
Support Year
5
Fiscal Year
2002
Total Cost
Indirect Cost
City
Dallas
State
TX
Country
United States
Zip Code
75390
Parra, Edwin R; Villalobos, Pamela; Mino, Barbara et al. (2018) Comparison of Different Antibody Clones for Immunohistochemistry Detection of Programmed Cell Death Ligand 1 (PD-L1) on Non-Small Cell Lung Carcinoma. Appl Immunohistochem Mol Morphol 26:83-93
Yamauchi, Mitsuo; Barker, Thomas H; Gibbons, Don L et al. (2018) The fibrotic tumor stroma. J Clin Invest 128:16-25
Ma, Junsheng; Hobbs, Brian P; Stingo, Francesco C (2018) Integrating genomic signatures for treatment selection with Bayesian predictive failure time models. Stat Methods Med Res 27:2093-2113
Yi, Faliu; Yang, Lin; Wang, Shidan et al. (2018) Microvessel prediction in H&E Stained Pathology Images using fully convolutional neural networks. BMC Bioinformatics 19:64
Song, Kai; Bi, Jia-Hao; Qiu, Zhe-Wei et al. (2018) A quantitative method for assessing smoke associated molecular damage in lung cancers. Transl Lung Cancer Res 7:439-449
Ji, Xuemei; Bossé, Yohan; Landi, Maria Teresa et al. (2018) Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk. Nat Commun 9:3221
He, Min; Liu, Shanshan; Gallolu Kankanamalage, Sachith et al. (2018) The Epithelial Sodium Channel (?ENaC) Is a Downstream Therapeutic Target of ASCL1 in Pulmonary Neuroendocrine Tumors. Transl Oncol 11:292-299
Parra, Edwin R; Villalobos, Pamela; Behrens, Carmen et al. (2018) Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches. J Immunother Cancer 6:48
Guo, Hou-Fu; Tsai, Chi-Lin; Terajima, Masahiko et al. (2018) Pro-metastatic collagen lysyl hydroxylase dimer assemblies stabilized by Fe2+-binding. Nat Commun 9:512
Meraz, Ismail M; Majidi, Mourad; Cao, Xiaobo et al. (2018) TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models. Cancer Immunol Res 6:163-177

Showing the most recent 10 out of 1059 publications